Kevin Alan Schulman, MD

Professor of Medicine
Director, Center for Clinical and Genetic Economics
Research Professor of Global Health
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Campus mail 6042 N Pavilion Bldg, Durham, NC 27710
Phone (919) 668-8101
Email address kevin.schulman@duke.edu

Kevin A. Schulman, MD, MBA, is a professor of medicine and the Gregory Mario and Jeremy Mario Professor of Business Administration (2010 - 2016) at Duke University. He is a visiting professor of business administration at Harvard Business School. He holds several leadership appointments at Duke. He is an associate director of the Duke Clinical Research Institute in the School of Medicine, the country's largest academic clinical research organization. In Duke's Fuqua School of Business, he served for more than a decade as the director of the Health Sector Management program, the Master of Management in Clinical Informatics degree program, and the Center for the Study of Health Management. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Medicine Institute; and the Duke Global Health Institute.

Dr. Schulman is a distinguished researcher who has received more than $48 million in research grants. His research interests include health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; health economics and economic evaluation in clinical research; and medical decision making, especially in patients with life-threatening conditions. He teaches courses in biotechnology, health policy, and health IT strategy.

Dr. Schulman has published nearly 400 articles and book chapters; his peer-reviewed papers have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is the senior associate editor of Health Services Research and a member of the editorial/advisory boards of the American Journal of Medicine and the American Heart Journal.

A recipient of numerous awards, Dr. Schulman is a fellow of the American College of Physicians and an elected member of the American Society for Clinical Investigation. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. He has served as session chair and panelist at dozens of medical and health care conferences. Dr. Schulman has also served on numerous grant review committees for the National Institutes of Health, the Robert Wood Johnson Foundation, and other bodies. He is a member of the advisory board for the Centre for Healthcare Policy and Management at the China Europe International Business School. In 2010-2011, he was a mentor for the Commonwealth Fund's Harkness Fellowships in Health Care Policy and Practice. He is the founding president of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.

Dr. Schulman received his MD from the New York University School of Medicine and his MBA, with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board-certified in internal medicine.

Education and Training

  • M.D., New York University, 1988
  • M.B.A., University of Pennsylvania, 1988

Publications

Hardy, M, Cho, A, Stavig, A, Bratcher, M, Dillard, J, Greenblatt, L, and Schulman, K. "Understanding Frequent Emergency Department Use Among Primary Care Patients." Population Health Management 21, no. 1 (February 2018): 24-31.

Full Text

Tseng, P, Kaplan, RS, Richman, BD, Shah, MA, and Schulman, KA. "Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System." JAMA 319, no. 7 (February 2018): 691-697.

PMID
29466590
Full Text

Maniya, OZ, Mather, RC, Attarian, DE, Mistry, B, Chopra, A, Strickland, M, and Schulman, KA. "Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model." The Journal of arthroplasty 32, no. 11 (November 2017): 3268-3273.e4.

PMID
28669568
Full Text

Clough, JD, Dinan, MA, and Schulman, KA. "Trends in hospital-physician integration in medical oncology." The American journal of managed care 23, no. 10 (October 2017): 624-627.

PMID
29087634
Scholars@Duke

Sendak, MP, Balu, S, and Schulman, KA. "Barriers to Achieving Economies of Scale in Analysis of EHR Data. A Cautionary Tale." Applied clinical informatics 8, no. 3 (August 9, 2017): 826-831.

PMID
28837212
Full Text

Mark, DB, and Schulman, KA. "PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability." JAMA 318, no. 8 (August 2017): 711-712.

PMID
28829851
Full Text

Dabora, MC, Turaga, N, and Schulman, KA. "Financing and Distribution of Pharmaceuticals in the United States." JAMA 318, no. 1 (July 2017): 21-22.

PMID
28505252
Full Text

Schulman, KA, and Reed, SD. "The economics of PCSK-9 inhibitors." American heart journal 189 (July 2017): 200-201. (Letter)

PMID
28625378
Full Text

Richman, BD, Kitzman, N, Milstein, A, and Schulman, KA. "Battling the chargemaster: A simple remedy to balance billing for unavoidable out-of-network care." American Journal of Managed Care 23, no. 4 (April 1, 2017).

Scholars@Duke

Levy, WC, Li, Y, Reed, SD, Zile, MR, Shadman, R, Dardas, T, Whellan, DJ, Schulman, KA, Ellis, SJ, Neilson, M, O'Connor, CM, and HFACTION Investigators, . "Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?." JACC. Clinical electrophysiology 3, no. 3 (March 2017): 291-298.

PMID
28553663
Full Text

Pages